"The COVID cartel's cover-up continues," Senate investigations Chair Ron Johnson says. FDA's advisers have repeatedly ...
The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the ...
Dec 16 (Reuters) - Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and treatment, price cuts promised to the U.S. government, and ...
Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year outlook as its Covid vaccine and antiviral pill Paxlovid helped boost sales. It ...
Pfizer on Tuesday reported fourth-quarter earnings and revenue that beat estimates as sales of the company's Covid products topped expectations and its broad cost-cutting efforts took hold. Stream ...
The FDA’s outside vaccine advisers plan to convene Thursday to recommend which Covid-19 strain vaccine manufacturers should target for the 2026-2027 season’s products, all while the country’s vaccine ...
According to the Centers for Disease Control and Prevention's COVID ⁠dashboard, new data is currently unavailable due to low ...
By Christy Santhosh May 28 (Reuters) - The U.S. FDA's advisory panel will vote on Thursday on whether COVID-19 vaccines for ...